GLP-1 Peptide Reconstitution and Storage in the Laboratory
Laboratory concentration math. Not administration, not injection. Research use only.
Lyophilized GLP-1-class peptides from PureLab Performance arrive as a dry cake or film. A laboratory working solution is made by dissolving a known mass in a known volume of solvent so that the concentration is known. That is arithmetic and handling. It is not administration.
Concentration math (including when the COA and the cap disagree), lyophilized handling, storage temperatures, and bacteriostatic water as a preserved aqueous solvent for laboratory prep. Not injection, not syringes as dosing devices, not “units” on a schedule. Handling sequence: Peptide Reconstitution 101. Mass-and-volume tool: reconstitution calculator. Research use only.
A note on why this page is written this tightly: in March 2026, FDA’s warning letter to Gram Peptides treated bacteriostatic water sold alongside peptide listings, together with metabolic copy, as evidence that the products were intended for human injection. Intended use is read from the whole site. This page is concentration and storage for laboratory solutions. If a sentence here could be read as a how-to-inject, it does not belong here. See what Research Use Only means.
The only equation that matters
Concentration is mass divided by volume:
C (mg/mL) = peptide mass (mg) ÷ solvent volume (mL)
The mass is fixed by what is in the vial. The volume is chosen by the laboratory. That single choice sets concentration for the working solution.
Examples, using *label* mass as the input:
| Label mass | Solvent added | Concentration |
|---|---|---|
| 5 mg | 1.0 mL | 5.0 mg/mL |
| 10 mg | 2.0 mL | 5.0 mg/mL |
| 15 mg | 3.0 mL | 5.0 mg/mL |
| 20 mg | 2.0 mL | 10.0 mg/mL |
| 30 mg | 3.0 mL | 10.0 mg/mL |
Those rows are arithmetic identities, not recommendations. Choose the concentration the protocol specifies, then add the volume that produces it. Or enter mass and target concentration in the calculator and read the solvent volume. Concentration tool, not a protocol.
Use the assayed mass when you have one
The table above assumes the vial contains the label mass. A Certificate of Analysis may say otherwise.
Retatrutide lot fghe8m6 (Krause Analytical, Austin, Texas, HPLC-UV-MS, report 5 August 2026) came back at 87.6% of the 30 mg label claim — 26.3 mg of 30 mg stated — with chromatographic purity >99.9%. Figures: retatrutide product page and How to read a GLP-1 peptide COA. Purity vs content: peptide purity and HPLC.
If a protocol needs 10 mg/mL of peptide, not 10 mg/mL of “whatever was written on the cap”:
- Label math: 30 mg ÷ 3.0 mL = 10.0 mg/mL
- Assay math: 26.3 mg ÷ 3.0 mL = 8.77 mg/mL
The second number is the concentration of the working solution for that lot. Using 30 mg in the numerator because it is a round number is how a laboratory writes down 10.0 mg/mL and actually has 8.77. For lots with no certificate yet — tirzepatide is currently LOT PENDING — there is no assayed mass to substitute. Do not invent one.
Content adjustments belong in the notebook next to the lot number. They do not belong in a human-use conversion chart. There is no such chart on this site.
Lyophilized powder: handle it as a dry solid
Until solvent is added, the peptide is a freeze-dried solid in a sealed vial. Practical handling, none of it administration:
- Confirm the label before you open anything. Compound, lot, and milligram claim. Lot fghe8m6 is not a 5 mg certificate, and a 5 mg vial is not a 30 mg fill.
- Let a frozen vial equilibrate, capped, before opening. Condensation on a cold cake adds unmeasured water and starts reconstitution whether you intended it or not.
- Keep the stopper in until the solvent step. Lyophilized peptides pick up moisture. Humidity is not a storage condition.
- Do not vortex the dry cake. Mechanical stress and foaming are how peptides degrade in solution; beating the solid around is not an improvement.
The solvent-addition details — down the glass wall, not onto the cake; swirl, never shake; wait for a clear solution unless the peptide is one of the known exceptions — are in Reconstitution 101. Measure solvent with a calibrated laboratory volumetric device. Record the volume you actually added, not the volume you meant to add.
Bacteriostatic water is a solvent, not a kit
Bacteriostatic water is sterile water containing 0.9% benzyl alcohol. The alcohol is a preservative. In a laboratory it is used as an aqueous solvent for reconstituting lyophilized peptides when the working solution will be sampled more than once. Sterile water without a preservative is the usual choice when the solution is prepared for a single use and not held.
That is solvent chemistry. It is not a complete-the-kit instruction.
FDA’s 31 March 2026 letter to Gram Peptides is explicit on the inference it drew: offering “Bacteriostatic Water for Injection” for sale alongside peptide products that require reconstitution was treated as evidence that the water was intended for use in combination for injection, and therefore as a drug. Metabolic benefit language on the same site supplied the intended-use half of that record.
So this page will not:
- pair solvent volumes with a weekly mass
- convert millilitres into “units”
- describe administration technique
- treat bacteriostatic water as an accessory to human use
If your protocol specifies a different solvent — dilute acetic acid, DMSO, a buffer — use the solvent the protocol specifies. Bacteriostatic water is common for aqueous laboratory prep of these peptides. It is not universal, and it is not a clinical vehicle as discussed here.
Opened bacteriostatic water has its own dating conventions; the figure people quote as “28 days” is not on the FDA label. Do not borrow that number as a peptide stability claim. It is not one.
Per-vial solvent volumes for retatrutide, as concentration tables rather than a protocol, are collected on How much bacteriostatic water for retatrutide. Read them as mass-and-volume identities. They are not administration instructions.
Storage: two states, two clocks
Lyophilized (unopened). Keep dry, protected from light, and cold. Many laboratories hold lyophilized research peptides at about −20 °C; short-term refrigeration (2–8 °C) is sometimes used when freeze–thaw of the unopened vial is the larger risk. Follow the storage line on the lot documentation when it exists. We do not publish an in-house shelf life we have not measured. A number copied from an unrelated peptide is not a stability study.
Reconstituted. Once solvent is in, you have an aqueous peptide solution. Typical laboratory hold is 2–8 °C, protected from light, capped. Freeze–thaw cycles of working solutions are a common way to lose material; if the protocol requires frozen aliquots, aliquot first rather than cycling the parent vial. Label compound, lot, concentration (using assayed mass when you have it), solvent, and date. The clock starts when the solvent goes in.
We do not print a universal “use within *n* days” for reconstituted GLP-1-class research peptides. Stability depends on sequence, concentration, solvent, container, and temperature. If a protocol or a lot-specific study states a window, that window wins. If none does, do not substitute a blog number.
Research Use Only still means not a drug as sold here, not a supplement, not for human or veterinary use. Retatrutide is investigational. Tirzepatide RUO material is not Mounjaro or Zepbound. Jastreboff et al., *N Engl J Med* 2023, is phase 2 investigational retatrutide under protocol — literature, not a reconstitution recipe, and not a reason to use the research reagent in a person. A correctly prepared laboratory solution does not change any of that.
Related reading
- Peptide Reconstitution 101 — laboratory handling sequence
- Reconstitution calculator — mass, volume, concentration
- How to read a GLP-1 peptide COA — assayed content versus label claim
- Peptide purity and HPLC
- What “Research Use Only” means
- How much bacteriostatic water for retatrutide — concentration tables by vial size
- GLP-1 research peptides hub
- Retatrutide — research peptide
- Tirzepatide — research peptide
Research Use Only (RUO). For laboratory research only. Not for human or veterinary use. Not a drug, not a supplement, not food. Not intended to diagnose, treat, cure, or prevent any disease. No statements on this page have been evaluated by the FDA. This page is not administration guidance.